MG
Murali Gopalan Latteri
About Murali Gopalan Latteri
Data last updated:
Murali Gopalan Latteri was a Director at Vmg Pharmaceuticals Private Limited (2008–2013), Additional Director at Caristar Laboratories Private Limited (2013–2018) and Director at Nusch Bio Sciences (India) Private Limited (2012–2018), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vmg Pharmaceuticals Private Limited U24100HR2008PTC092142 | Director | 20 Nov 2008 | 2008 | ₹2.17 Cr (FY 2025) | Active |
 Caristar Laboratories Private Limited U24233MH2011PTC223522 | Additional Director | 23 Jun 2013 | 2011 | ₹6.69 Cr (FY 2025) | Active |
 Nusch Bio Sciences (India) Private Limited U24232DL2006PTC145468 | Director | 15 Oct 2012 | 2006 | Active | |
| Cellzest Lifesciences Private Limited U24100DL2011PTC224787 | Director | 03 Jun 2013 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Gopalan Latteri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Gopalan Latteri
Murali Gopalan Latteri was first appointed on 20 Nov 2008 as Director at Vmg Pharmaceuticals Private Limited. The most recent appointment on record is 23 Jun 2013 at Caristar Laboratories Private Limited.
Murali Gopalan Latteri held 4 earlier board appointments: Vmg Pharmaceuticals Private Limited (Director, 20 Nov 2008 to 01 May 2013); Caristar Laboratories Private Limited (Additional Director, 23 Jun 2013 to 13 Oct 2018); Nusch Bio Sciences (India) Private Limited (Director, 15 Oct 2012 to 13 Oct 2018); Cellzest Lifesciences Private Limited (Director, from 03 Jun 2013).